ChemicalBook--->CAS DataBase List--->2748469-74-9

2748469-74-9

Request For Quotation
2748469-74-9 Structure

2748469-74-9 Structure
IdentificationBack Directory
[Name]

INDEX NAME NOT YET ASSIGNED
[CAS]

2748469-74-9
[Synonyms]

[Molecular Formula]

C15H22ClNO2
[MOL File]

2748469-74-9.mol
[Molecular Weight]

283.8
Safety DataBack Directory
[Symbol(GHS) ]

Flame (GHS02)Skull and Crossbones (GHS06)Health Hazard (GHS08)
GHS02,GHS06,GHS08
[Signal word ]

Danger
[Hazard statements ]

H225-H301+H311+H331-H370
[Precautionary statements ]

P210-P240-P241-P242-P243-P260-P264-P270-P271-P280-P301+P310-P321-P330-P303+P361+P353-P304+P340-P307+P311-P312-P361+P364-P370+P378-P403+P233-P403+P235-P405-P501
Hazard InformationBack Directory
[Description]

Meperidine-d4 (hydrochloride) (CRM) is a certified reference material intended for use as an internal standard for the quantification of meperidine by GC- or LC-MS. Meperidine is categorized as an opioid.1 It is an opioid analgesic that is commonly abused.2 Meperidine is regulated as a Schedule II compound in the United States. Meperidine-d4 (hydrochloride) (CRM) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.
[References]

1. Ossipov, M.H., Harris, S., Lloyd, P., et al. Antinociceptive interaction between opioids and medetomidine: Systemic additivity and spinal synergy Anesthesiology 73(6),1227-1235(1990).
2. Atluri, S.A., Sudarshan, G., and Manchikanti, L. Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011 Pain Physician 17(2),E119-E128(2014).
2748469-74-9 suppliers list
Tags:2748469-74-9 Related Product Information
50-13-5 1435934-57-8 1330180-05-6 2749974-94-3 2749394-90-7